Ethicon Physiomesh Case To Go Before Federal Juries in November 2020, February 2021 and May 2021

The U.S. District Judge presiding over all federal Ethicon Physiomesh lawsuits has set the first bellwether trial date to begin in November 2020, with a second case set to go before a jury in February 2021 and a third consolidated trial involving multiple plaintiffs will go forward in May 2021, unless a settlement or resolution for the hernia mesh litigation is reached.

Ethicon Physiomesh is a multi-layered, flexible composite hernia mesh product introduced by Johnson & Johnson’s Ethicon subsidiary in 2010. However, the manufacturer removed the product from the market only six years later, amid a large number of complaints involving complications with the hernia mesh, often resulting in the need for additional surgery to remove it from individuals’ bodies.

There are currently nearly 2,800 hernia mesh lawsuits filed throughout the federal court system involving problems with Ethicon Physiomesh, each raising similar allegations that the manufacturer sold a defective and unreasonably dangerous product, which caused plaintiffs to suffer severe abdominal pain, infection, hernia recurrence, adhesions, perforations, erosion and other injuries associated with failure of the hernia mesh.

Hernia Mesh Lawsuits

Did you or a loved one receive a hernia mesh?

Hernia mesh lawsuits are being filed against Bard, Atrium, Covidien and several other hernia mesh manufacturers over mesh failures resulting in injuries and additional surgery.

Learn More About this Lawsuit See If You Qualify For Compensation

Given similar questions of fact and law, the federal cases are centralized for pretrial proceedings before U.S. District Judge Richard Story in the Northern District of Georgia, as part of an MDL, or multidistrict litigation.

In a practice and procedure order (PDF) issued last month, Judge Story announced that the parties have selected four cases for immediate trial workup. The expert discovery for those cases is scheduled to be completed by July 15, in preparation for a series of early trial dates designed to help the parties gauge how juries are likely to respond to certain evidence and testimony that will likely be repeated throughout thousands of cases.

The order indicates that plaintiffs will get to select the first trial by the middle of next month, with dispositive or Daubert motions challenging the admissibility of expert witness testimony to be filed by July 31. Following a final pretrial conference on October 22, the first trial will begin on November 2, 2020, and is estimated to last two to three weeks.

By July 15, Defendants will also make a selection for the second case to go to trial, with dispositive or Daubert motions in that claim due by December 1, and trial set to begin on February 22, 2021.

A third trial has been set for May 10, 2021, and is expected to involve multiple plaintiffs that will go before the same jury, which would last about three to four weeks.

While the outcomes of these early “test” cases will not be binding on other plaintiffs, they will be closely watched by lawyers involved in the litigation, and are designed to help the parties weigh the relative strengths and weaknesses of their arguments.

How the jury responds to certain evidence in the cases will also greatly influence any eventually hernia mesh settlements Ethicon may offer to avoid the need for thousands of future claims to go before juries nationwide.

Although it has been several years since the hernia mesh was removed from the market, as individuals continue to experience complications caused by an Ethicon Physiomesh failure, the size of the litigation is expected to continue to increase over the coming months and years.

Following the bellwether trials, if Johnson & Johnson and it’s Ethicon unit fail to settle claims or otherwise resolve the litigation, each individual claim pending before Judge Story may later be remanded back to the U.S. District Court where it was originally filed, for a separate trial date.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted yesterday)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 3 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.